MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis

Simple item page
dc.contributor.authorLuis Antonio Díaz
dc.contributor.authorEduardo Fuentes–López
dc.contributor.authorGustavo Ayares
dc.contributor.authorFrancisco Idalsoaga
dc.contributor.authorJorge Arnold
dc.contributor.authorMaría Ayala-Valverde
dc.contributor.authorDiego Pérez
dc.contributor.authorJaime Gómez
dc.contributor.authorRodrigo Escarate
dc.contributor.authorAlejandro Villalón
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T13:58:30Z
dc.date.available2026-03-22T13:58:30Z
dc.date.issued2023
dc.descriptionCitaciones: 30
dc.identifier.doi10.1016/j.jhepr.2023.100727
dc.identifier.urihttps://doi.org/10.1016/j.jhepr.2023.100727
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/43811
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofJHEP Reports
dc.sourcePontificia Universidad Católica de Chile
dc.subjectRenal replacement therapy
dc.subjectMedicine
dc.subjectIntensive care medicine
dc.subjectAlcohol
dc.subjectInternal medicine
dc.titleMELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis
dc.typearticle

Files

Collections

Artículo Científico Publicado